Dana DiRenzo1, Clifton O Bingham1, Christopher A Mecoli2. 1. The Johns Hopkins University School of Medicine, 5200 Eastern Avenue, MFL Building, Center Tower, Suite 4100, Baltimore, MD, 21224, USA. 2. The Johns Hopkins University School of Medicine, 5200 Eastern Avenue, MFL Building, Center Tower, Suite 4100, Baltimore, MD, 21224, USA. cmecoli1@jhmi.edu.
Abstract
PURPOSE OF REVIEW: Idiopathic inflammatory myopathies (IIM) have considerable impact on patient symptoms and quality of life. We have reviewed the evolution of patient-centered care and use of patient-reported outcome measures (PROMs) for adults with IIM. RECENT FINDINGS: Use of PROMs in myositis care and research is limited, although the importance of incorporation into routine practice and trials has become increasingly recognized. Several key domains/measures have been identified including the patient global assessment of disease activity, physical function as measured by the health assessment questionnaire-disability index (HAQ-DI), Short Form Health Survey-36 (SF-36), or the Patient-Reported Outcome Measurement Information System ® (PROMIS®) in adult IIM. Data are limited for these instruments concerning their reliability, content and construct validity, and responsiveness. Incorporation of the patient perspective into clinical care and research may be used to address the unmet/unaddressed needs of the patient living with myositis. Several ongoing projects aim to bring validated PROMs to the IIM community.
PURPOSE OF REVIEW: Idiopathic inflammatory myopathies (IIM) have considerable impact on patient symptoms and quality of life. We have reviewed the evolution of patient-centered care and use of patient-reported outcome measures (PROMs) for adults with IIM. RECENT FINDINGS: Use of PROMs in myositis care and research is limited, although the importance of incorporation into routine practice and trials has become increasingly recognized. Several key domains/measures have been identified including the patient global assessment of disease activity, physical function as measured by the health assessment questionnaire-disability index (HAQ-DI), Short Form Health Survey-36 (SF-36), or the Patient-Reported Outcome Measurement Information System ® (PROMIS®) in adult IIM. Data are limited for these instruments concerning their reliability, content and construct validity, and responsiveness. Incorporation of the patient perspective into clinical care and research may be used to address the unmet/unaddressed needs of the patient living with myositis. Several ongoing projects aim to bring validated PROMs to the IIM community.
Authors: Lucy Busija; Eva Pausenberger; Terry P Haines; Sharon Haymes; Rachelle Buchbinder; Richard H Osborne Journal: Arthritis Care Res (Hoboken) Date: 2011-11 Impact factor: 4.794
Authors: Lisa G Rider; Edward H Giannini; Michael Harris-Love; Galen Joe; David Isenberg; Clarissa Pilkington; Peter A Lachenbruch; Frederick W Miller Journal: J Rheumatol Date: 2003-03 Impact factor: 4.666
Authors: Lisa G Rider; Edward H Giannini; Hermine I Brunner; Nicola Ruperto; Laura James-Newton; Ann M Reed; Peter A Lachenbruch; Frederick W Miller Journal: Arthritis Rheum Date: 2004-07
Authors: D A Isenberg; E Allen; V Farewell; M R Ehrenstein; M G Hanna; I E Lundberg; C Oddis; C Pilkington; P Plotz; D Scott; J Vencovsky; R Cooper; L Rider; F Miller Journal: Rheumatology (Oxford) Date: 2003-07-16 Impact factor: 7.580
Authors: Vivek Nagaraja; Constance Mara; Puja P Khanna; Rajaie Namas; Amber Young; David A Fox; Timothy Laing; William J McCune; Carol Dodge; Debra Rizzo; Maha Almackenzie; Dinesh Khanna Journal: Qual Life Res Date: 2017-10-05 Impact factor: 4.147
Authors: Barbora Heřmánková; Maja Špiritović; Sabína Oreská; Hana Štorkánová; Martin Komarc; Martin Klein; Heřman Mann; Karel Pavelka; Ladislav Šenolt; Jiří Vencovský; Michal Tomčík Journal: Rheumatology (Oxford) Date: 2021-11-03 Impact factor: 7.580